UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Current management strategies and long‐term clinical outcomes of upper extremity venous thrombosis

Journal of thrombosis and haemostasis, 2016-05, Vol.14 (5), p.973-981

2016

Volltextzugriff (PDF)

Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study

Journal of thrombosis and haemostasis, 2015-06, Vol.13 (6), p.1019-1027

2015

Volltextzugriff (PDF)

Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)

Journal of thrombosis and haemostasis, 2012-04, Vol.10 (4), p.622-631

2012

Volltextzugriff (PDF)

Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry

Blood, 2012-07, Vol.120 (1), p.39-46

2012

Volltextzugriff (PDF)

Current management strategies and long‐term clinical outcomes of upper extremity venous thrombosis

Journal of thrombosis and haemostasis, 2016-05, Vol.14 (5), p.973-981

2016

Volltextzugriff (PDF)

OC 29.1 Long-Term Outcomes of COVID-19 Associated Venous Thromboembolism (VTE)

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.100364, Article 100364

2023

Volltextzugriff (PDF)

Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)

Blood, 2012-07, Vol.120 (1), p.47-55

2012

Volltextzugriff (PDF)

Bleeding Risk in Very Old Patients on Vitamin K Antagonist Treatment: Results of a Prospective Collaborative Study on Elderly Patients Followed by Italian Centres for Anticoagulation

Circulation (New York, N.Y.), 2011-08, Vol.124 (7), p.824-829

2011

Volltextzugriff (PDF)

The predictive ability of bleeding risk stratification models in very old patients on vitamin K antagonist treatment for venous thromboembolism: results of the prospective collaborative EPICA study

Journal of thrombosis and haemostasis, 2013-06, Vol.11 (6), p.1053-1058

2013

Volltextzugriff (PDF)

Statins under-treatment and mortality in patients with atrial fibrillation. Insights from the nationwide START registry

Nutrition, metabolism, and cardiovascular diseases, 2023-11, Vol.33 (11), p.2261-2268

2023

Volltextzugriff (PDF)

Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry

BJOG : an international journal of obstetrics and gynaecology, 2012-11, Vol.119 (12), p.1529-1537

2012

Volltextzugriff (PDF)

The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation

PloS one, 2015-05, Vol.10 (5), p.e0124719-e0124719

2015

Volltextzugriff (PDF)

Thrombocytopenia and Mortality Risk in Patients With Atrial Fibrillation: An Analysis From the START Registry

Journal of the American Heart Association, 2019-11, Vol.8 (21), p.e012596-e012596

2019

Volltextzugriff (PDF)

Treatment and long-term clinical outcomes of incidental pulmonary embolism in cancer patients: an international prospective cohort study

Thrombosis research, 2018-04, Vol.164, p.S193-S194

2018

Volltextzugriff (PDF)

Low in-hospital mortality rate in patients with COVID-19 receiving thromboprophylaxis: data from the multicentre observational START-COVID Register

Internal and emergency medicine, 2022-06, Vol.17 (4), p.1013-1021

2022

Volltextzugriff (PDF)

Vitamin K antagonist therapy: changes in the treated populations and in management results in Italian anticoagulation clinics compared with those recorded 20 years ago

Internal and emergency medicine, 2017-12, Vol.12 (8), p.1109-1119

2017

Volltextzugriff (PDF)

Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register

BMJ open, 2020-11, Vol.10 (11), p.e040449

2020

Volltextzugriff (PDF)

Institutional performance and dose intensity as prognostic factors in adult ALL

Leukemia, 1995-05, Vol.9 (5), p.933-934

1995

Volltextzugriff (PDF)

The use of anthracyclines in adult acute lymphoblastic leukemia

Haematologica (Roma), 1995-05, Vol.80 (3), p.280

1995

Volltextzugriff (PDF)

Risk-oriented postremission strategies in adult acute lymphoblastic leukemia: prospective confirmation of anthracycline activity in standard-risk class and role of hematopoietic stem cell transplants in high-risk groups

The hematology journal : the official journal of the European Haematology Association, 2001, Vol.2 (2), p.117-126

2001

Volltextzugriff (PDF)

Venous thromboembolism secondary to hospitalization for COVID-19: patient management and long-term outcomes

Research and practice in thrombosis and haemostasis, 2023-05, Vol.7 (4), p.100167-100167, Article 100167

2023

Volltextzugriff (PDF)

The Role of Idarubicin in Adult Acute Lymphoblastic Leukaemia: From Drug Resistance Studies to Clinical Application

Leukemia & lymphoma, 1997-01, Vol.26 (S1), p.89-97

1997

Volltextzugriff (PDF)

Phase I trial with escalating doses of idarubicin and multidrug resistance reversal by short-course cyclosporin A, sequential high-dose cytosine arabinoside, and granulocyte colony-stimulating factor for adult patients with refractory acute leukemia

Haematologica (Roma), 2002-03, Vol.87 (3), p.257

2002

Volltextzugriff (PDF)

Transplant-finalized salvage of adult acute lymphoblastic leukemia: results of a mitoxantrone- and methotrexate-based regimen in 36 patients

Leukemia & lymphoma, 2005-06, Vol.46 (6), p.879-884

2005

Volltextzugriff (PDF)

Strategies for the treatment of recurrent acute lymphoblastic leukemia in adults

Haematologica (Roma), 1996-01, Vol.81 (1), p.20

1996

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(66)

Publikationsform

Sprache

Englisch
(86)
Französisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(65)
Life Sciences & Biomedicine
(49)
Humans
(44)
Female
(30)
Male
(30)
Hematology
(29)
Middle Aged
(28)
Adult
(25)
Aged
(21)
Adolescent
(15)
Technology
(15)
Treatment Outcome
(14)
Energy & Fuels
(13)
Risk Factors
(13)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(12)
Biological And Medical Sciences
(12)
Cardiovascular System & Cardiology
(12)
Medical Sciences
(12)
Precursor Cell Lymphoblastic Leukemia-Lymphoma - Drug Therapy
(12)
Aged, 80 And Over
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Current management strategies and long‐term clinical outcomes of upper extremity venous thrombosis

Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study

Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)

Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry

Current management strategies and long‐term clinical outcomes of upper extremity venous thrombosis

OC 29.1 Long-Term Outcomes of COVID-19 Associated Venous Thromboembolism (VTE)

Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)

Bleeding Risk in Very Old Patients on Vitamin K Antagonist Treatment: Results of a Prospective Collaborative Study on Elderly Patients Followed by Italian Centres for Anticoagulation

The predictive ability of bleeding risk stratification models in very old patients on vitamin K antagonist treatment for venous thromboembolism: results of the prospective collaborative EPICA study

Statins under-treatment and mortality in patients with atrial fibrillation. Insights from the nationwide START registry

Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry

The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation

Thrombocytopenia and Mortality Risk in Patients With Atrial Fibrillation: An Analysis From the START Registry

Treatment and long-term clinical outcomes of incidental pulmonary embolism in cancer patients: an international prospective cohort study

Low in-hospital mortality rate in patients with COVID-19 receiving thromboprophylaxis: data from the multicentre observational START-COVID Register

Vitamin K antagonist therapy: changes in the treated populations and in management results in Italian anticoagulation clinics compared with those recorded 20 years ago

Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register

Institutional performance and dose intensity as prognostic factors in adult ALL

The use of anthracyclines in adult acute lymphoblastic leukemia

Risk-oriented postremission strategies in adult acute lymphoblastic leukemia: prospective confirmation of anthracycline activity in standard-risk class and role of hematopoietic stem cell transplants in high-risk groups

Venous thromboembolism secondary to hospitalization for COVID-19: patient management and long-term outcomes

The Role of Idarubicin in Adult Acute Lymphoblastic Leukaemia: From Drug Resistance Studies to Clinical Application

Phase I trial with escalating doses of idarubicin and multidrug resistance reversal by short-course cyclosporin A, sequential high-dose cytosine arabinoside, and granulocyte colony-stimulating factor for adult patients with refractory acute leukemia

Transplant-finalized salvage of adult acute lymphoblastic leukemia: results of a mitoxantrone- and methotrexate-based regimen in 36 patients

Strategies for the treatment of recurrent acute lymphoblastic leukemia in adults

Suchergebnisse filtern